menu
    • menu

    Company profile for RenovoRx

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RenovoRx is developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents such as chemotherapy, to selected sites in the peripheral vascular system. Delivering these agents at a high concentration to specific vasculature – safely and without perfusion to other regions – is a central paradigm of our technology. RenovoRx has developed the RenovoCath, which is FDA cleared and ...
    RenovoRx is developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents such as chemotherapy, to selected sites in the peripheral vascular system. Delivering these agents at a high concentration to specific vasculature – safely and without perfusion to other regions – is a central paradigm of our technology. RenovoRx has developed the RenovoCath, which is FDA cleared and now being investigated in an active clinical trial to prove extended median survival and improved quality of life.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RenovoRxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4546 El Camino Real Suite 223 Los Altos, CA 94022
    Telephone
    Telephone
    (650) 284-4433
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://renovorx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BD&L Summit

    BD&L Summit

    Not Confirmed

    envelop Contact Supplier

    BD&L Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Renovorx Showcases TAMP Therapy Data At 2026 SIR Conference
    Renovorx Showcases TAMP Therapy Data At 2026 SIR Conference

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273372/0/en/Clinical-Data-Supporting-Targeted-Chemotherapeutic-Delivery-via-RenovoRx-s-TAMP-Therapy-Platform-Presented-at-2026-SIR-Annual-Scientific-Meeting.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    RenovoRx Reports Full-Year 2025 Financials, Highlights
    RenovoRx Reports Full-Year 2025 Financials, Highlights

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3265014/0/en/RenovoRx-Reports-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    RenovoRx TIGeR-PaC Ph3 Hits 100 Patients Enrollment
    RenovoRx TIGeR-PaC Ph3 Hits 100 Patients Enrollment

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263006/0/en/RenovoRx-Announces-Key-Phase-III-Milestone-TIGeR-PaC-Trial-Surpasses-100-Randomized-Patients-as-Study-Nears-Completion-of-Enrollment.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    RenovoRx Closes Oversubscribed $10M At-the-Market Placement
    RenovoRx Closes Oversubscribed $10M At-the-Market Placement

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260378/0/en/RenovoRx-Announces-Closing-of-Oversubscribed-10-Million-at-Market-Private-Placement.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    RenovoRx To Host Q4 2025 Financial Results Conference Call
    RenovoRx To Host Q4 2025 Financial Results Conference Call

    20 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/20/3259718/0/en/RenovoRx-to-Host-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Business-Highlights-Conference-Call-on-March-30th-at-4-30-p-m-ET.html

    GLOBENEWSWIRE
    20 Mar 2026
    Share Share
    RenovoRx Announces $10 Million At Market Private Placement
    RenovoRx Announces $10 Million At Market Private Placement

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258176/0/en/RenovoRx-Announces-10-Million-at-Market-Private-Placement.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search